Evidence map›Paper›PMID 17635890›Full record

ArticleJAMA2007

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.

Børge G Nordestgaard, Marianne Benn, Peter Schnohr, Anne Tybjaerg-Hansen

3 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in JAMA, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 714 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
714citing papers in PubMed, 6 pooled it
76.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02770872 completednot on this mapstarted 2014, after this paper: background citation

The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk

TypeobservationalSponsorLisa TannockRan2014 to 2018Enrolled19ConditionsCardiovascular DiseaseArmsObservation of SAA on apoB containing lipoproteins
NCT05291767 naterminatednot on this mapstarted 2022, after this paper: background citation

The Effect of Moderate-Intensity Exercise on Postprandial Plasma Triglyceride Levels Following a High Fat Meal

TypeinterventionalSponsorUniversity of VirginiaRan2022 to 2022Enrolled7ConditionsKetogenic Diet, ExerciseArmsDiet, Exercise
NCT06501287 unknown statusnot on this mapstarted 2024, after this paper: background citation

Postprandial Triglyceride Impact on Coronary Atherosclerosis in Non-Diabetic Patient in Sohag University Hospital [NCT ID Not Yet Assigned]

TypeobservationalSponsorFatma Madhy EissaRan2024 to 2024Enrolled160ConditionsCoronary AtherosclerosesArmsPostprandial triglyceride
3 · Its place in the literature

Who cites it

714 citing papers in PubMed, 6 syntheses or guidelines pooled it, 2,041 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Review
  20. Article

654 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Børge G NordestgaardDepartment of Clinical Biochemistry, Herlev University Hospital, Herlev, Denmark. brno@heh.regionh.dk
Marianne Benn
Peter Schnohr
Anne Tybjaerg-Hansen
Herlev Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextElevated nonfasting triglycerides indicate the presence of remnant lipoproteins, which may promote atherosclerosis.

objectiveTo test the hypothesis that very high levels of nonfasting triglycerides predict myocardial infarction (MI), ischemic heart disease (IHD), and death. DESIGN, SETTING, AND

participantsA prospective cohort study of 7587 women and 6394 men from the general population of Copenhagen, Denmark, aged 20 to 93 years, followed up from baseline (1976-1978) until 2004.

main outcome measuresHazard ratios (HRs) for incident MI, IHD, and total death according to baseline nonfasting triglyceride level categories of 1 to 1.99 mmol/L (88.5-176.1 mg/dL), 2 to 2.99 mmol/L (177.0-264.6 mg/dL), 3 to 3.99 mmol/L (265.5-353.0 mg/dL), 4 to 4.99 mmol/L (354.0-441.6 mg/dL), and 5 mmol/L or more (> or =442.5 mg/dL) vs triglyceride levels of less than 1 mmol/L (<88.5 mg/dL).

resultsWith increasing levels of nonfasting triglycerides, levels of remnant lipoprotein cholesterol increased. During a mean follow-up of 26 years, 1793 participants (691 women and 1102 men) developed MI, 3479 (1567 women and 1912 men) developed IHD, and 7818 (3731 women and 4087 men) died. For MI, among women, the age-adjusted HRs and multifactorially adjusted HRs (aHRs) for each respective category per 1-mmol/L increase in nonfasting triglyceride levels were 2.2 (aHR, 1.7), 4.4 (aHR, 2.5), 3.9 (aHR, 2.1), 5.1 (aHR, 2.4), and 16.8 (aHR, 5.4); for both, P for trend < .001. For MI, among men, the values were 1.6 (aHR, 1.4), 2.3 (aHR, 1.6), 3.6 (aHR, 2.3), 3.3 (aHR, 1.9), and 4.6 (aHR, 2.4); for both, P for trend < .001. For IHD, among women, the values were 1.7 (aHR, 1.4), 2.8 (aHR, 1.8), 3.0 (aHR, 1.8), 2.1 (aHR, 1.2), and 5.9 (aHR, 2.6); for both, P for trend < .001. For IHD, among men, the values were 1.3 (aHR, 1.1), 1.7 (aHR, 1.3), 2.1 (aHR, 1.3), 2.0 (aHR, 1.2), and 2.9 (aHR, 1.5); P for trend < .001 for age-adjusted and P for trend = .03 for multifactorially adjusted. For total death, among women, the values were 1.3 (aHR, 1.3), 1.7 (aHR, 1.6), 2.2 (aHR, 2.2), 2.2 (aHR, 1.9), and 4.3 (aHR, 3.3); for both, P for trend < .001. For total death, among men, the values were 1.3 (aHR, 1.2), 1.4 (aHR, 1.4), 1.7 (aHR, 1.5), 1.8 (aHR, 1.6), and 2.0 (aHR, 1.8); for both, P for trend < .001.

conclusionIn this general population cohort, elevated nonfasting triglyceride levels were associated with increased risk of MI, IHD, and death in men and women.

Indexed as

AdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansHypertriglyceridemiaLipoproteinsMaleMiddle AgedMyocardial InfarctionMyocardial IschemiaPostprandial PeriodProportional Hazards ModelsProspective StudiesRiskLipoproteinsTriglycerides

Identifiers

PMID17635890
OpenAlexW2169582126

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.